Our Quality Management System provides guidance and resources to ensure that Imperial College London Diabetes Centre is continually compliant with the highest healthcare quality and patient safety standards as set by the Department of Health-Abu Dhabi (DOH), and other accreditation and regulatory authorities.
In 2021, Imperial College London Diabetes Centre (ICLDC) has been approved as a Centre of Excellence by the International Diabetes Federation (IDF). It joins a prestigious global network of diabetes institutions that initiates, coordinates, facilitates and conducts holistic diabetes services and multidisciplinary education in diabetes and related chronic diseases.
In 2021 Imperial College London Diabetes Centre has become the first in Abu Dhabi and the third in the UAE to be accredited as a Collaborating Centre for Obesity Management (COM) by the European Association for the Study of Obesity (EASO). Under the EASO COM scheme, obesity management centres are accredited against a set of stringent criteria and in accordance with accepted European and academic guidelines to ensure consistently high standards in different countries across the world.
Imperial College London Diabetes Centre holds the highly prestigious Joint Commission International (JCI) accreditation and certification for high standards of care at the Centre’s two locations in Abu Dhabi and Al Ain.
The JCI Gold Seal of Approval®, represents a symbol of quality that reflects an organisation’s commitment to providing safe and effective patient care and is highly regarded by the healthcare sector.
Imperial College London Diabetes Centre has been at the forefront of international accreditation in the country since it became the first healthcare provider worldwide in 2010 to receive both the JCI Clinical Care Program Certification (CCPC) for Diabetes Management and the JCI Accreditation for Ambulatory Care. At the same time, it also became the first facility in the Middle East and the third around the world to hold JCI’s highly-acclaimed CCPC specifically for the clinical management of diabetes. The Centres in Abu Dhabi and Al Ain were reaccredited in February 2022.
The CAP Laboratory Accreditation program is a worldwide leader in laboratory quality assurance, improving patient safety by ensuring laboratories meet or exceed regulatory requirements. CAP has accredited NRL managed laboratory in Imperial College London Diabetes Center.
The National Reference Laboratory (NRL) managed laboratory at Imperial College London Diabetes Centre is also ISO 15189:2012 accredited.
In 2024, M42 achieved the prestigious Global Healthcare Accreditation (GHA) Certification for Excellence in Medical Travel Patient Experience from the United States for its pioneering approach. With an outstanding overall score of 91 percent, this certification reaffirms M42's commitment to delivering exceptional care and support to international patients throughout their journey. M42 now joins the elite ranks of globally recognized healthcare providers by securing the GHA Medical Travel Patient Experience Certification, marking a significant milestone in advancing the region's medical tourism sector.
We partner with multiple
insurance companies
Find locations to HQ and
all our centers
We offer a comprehensive
range of diabetes and related services.
Get In Touch with Us
